‘Internal’ Market Conditioning Delivers Global PR Buy-in

When preparing to launch a new drug globally, pharmaceutical companies have come to understand the value of "external market conditioning" - a process of starting early to create fertile ground for new product acceptance among medical thought leaders and advocacy groups.

Corporate PR executives should adopt the same philosophy and condition the "internal marketplace" of their affiliate offices in other countries when looking for global PR buy-in.